Anavex Life Sciences Corp (AVXL)

[nidan7500]

bear...AGAIN, I find myself agreeing with your rationale and other thoughts on why we are where we are. It's the WHAT'S NEXT part that has us hanging by our fingertips.

We are looking at a potential binary event, no going back if A2-73 continues to perform. The platform science has been explained, the trial results have been published, plans have been carefully defined, resources seem to be lined up. It is a ONE or a ZERO, with evidence pointing to a massive win.

BTW, I also thought we stayed out of AAIC b/c with new FDA protocols being announced the context for any plans would be mixed at best. We cannot discuss what happens next until FDA defines new protocols.